東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/26 | 2,267 | 2,268 | 2,254 | 2,259 | -9 | -0.4% | 93,000 |
2022/08/25 | 2,293 | 2,293 | 2,268 | 2,268 | -12 | -0.5% | 72,200 |
2022/08/24 | 2,288 | 2,300 | 2,275 | 2,280 | -8 | -0.3% | 80,600 |
2022/08/23 | 2,305 | 2,306 | 2,286 | 2,288 | -38 | -1.6% | 81,800 |
2022/08/22 | 2,285 | 2,326 | 2,281 | 2,326 | +21 | +0.9% | 81,100 |
2022/08/19 | 2,309 | 2,317 | 2,297 | 2,305 | -13 | -0.6% | 90,100 |
2022/08/18 | 2,318 | 2,327 | 2,308 | 2,318 | -15 | -0.6% | 61,600 |
2022/08/17 | 2,332 | 2,359 | 2,319 | 2,333 | +33 | +1.4% | 146,500 |
2022/08/16 | 2,324 | 2,326 | 2,295 | 2,300 | -33 | -1.4% | 99,200 |
2022/08/15 | 2,353 | 2,372 | 2,328 | 2,333 | +11 | +0.5% | 157,400 |
2022/08/12 | 2,344 | 2,375 | 2,306 | 2,322 | -137 | -5.6% | 256,500 |
2022/08/10 | 2,465 | 2,470 | 2,450 | 2,459 | -13 | -0.5% | 28,500 |
2022/08/09 | 2,479 | 2,505 | 2,462 | 2,472 | -6 | -0.2% | 48,500 |
2022/08/08 | 2,500 | 2,501 | 2,463 | 2,478 | -31 | -1.2% | 51,300 |
2022/08/05 | 2,430 | 2,519 | 2,425 | 2,509 | +56 | +2.3% | 100,500 |
2022/08/04 | 2,434 | 2,457 | 2,410 | 2,453 | +29 | +1.2% | 70,900 |
2022/08/03 | 2,450 | 2,466 | 2,422 | 2,424 | -27 | -1.1% | 59,000 |
2022/08/02 | 2,528 | 2,530 | 2,449 | 2,451 | -104 | -4.1% | 57,400 |
2022/08/01 | 2,516 | 2,555 | 2,516 | 2,555 | +29 | +1.1% | 51,800 |
2022/07/29 | 2,610 | 2,610 | 2,525 | 2,526 | -84 | -3.2% | 58,100 |
2022/07/28 | 2,571 | 2,612 | 2,559 | 2,610 | +23 | +0.9% | 56,600 |
2022/07/27 | 2,563 | 2,602 | 2,563 | 2,587 | +10 | +0.4% | 34,400 |
2022/07/26 | 2,615 | 2,615 | 2,573 | 2,577 | -46 | -1.8% | 48,500 |
2022/07/25 | 2,647 | 2,647 | 2,609 | 2,623 | -20 | -0.8% | 78,700 |
2022/07/22 | 2,640 | 2,648 | 2,615 | 2,643 | +10 | +0.4% | 46,400 |
2022/07/21 | 2,587 | 2,638 | 2,575 | 2,633 | +46 | +1.8% | 94,000 |
2022/07/20 | 2,584 | 2,600 | 2,569 | 2,587 | +40 | +1.6% | 68,200 |
2022/07/19 | 2,566 | 2,566 | 2,524 | 2,547 | -8 | -0.3% | 63,000 |
2022/07/15 | 2,605 | 2,606 | 2,548 | 2,555 | -51 | -2% | 103,100 |
2022/07/14 | 2,566 | 2,607 | 2,560 | 2,606 | +22 | +0.9% | 66,400 |
2022/07/13 | 2,562 | 2,638 | 2,553 | 2,584 | -112 | -4.2% | 130,300 |
2022/07/12 | 2,695 | 2,705 | 2,675 | 2,696 | +11 | +0.4% | 88,700 |
2022/07/11 | 2,660 | 2,691 | 2,645 | 2,685 | +55 | +2.1% | 78,000 |
2022/07/08 | 2,602 | 2,656 | 2,590 | 2,630 | +30 | +1.2% | 115,700 |
2022/07/07 | 2,595 | 2,605 | 2,580 | 2,600 | +26 | +1% | 52,800 |
2022/07/06 | 2,538 | 2,575 | 2,529 | 2,574 | +8 | +0.3% | 51,900 |
2022/07/05 | 2,540 | 2,568 | 2,519 | 2,566 | +31 | +1.2% | 138,400 |
2022/07/04 | 2,493 | 2,539 | 2,493 | 2,535 | +69 | +2.8% | 63,400 |
2022/07/01 | 2,463 | 2,493 | 2,446 | 2,466 | +3 | +0.1% | 79,900 |
2022/06/30 | 2,439 | 2,485 | 2,439 | 2,463 | +28 | +1.1% | 100,600 |
2022/06/29 | 2,440 | 2,446 | 2,415 | 2,435 | -22 | -0.9% | 111,300 |
2022/06/28 | 2,399 | 2,464 | 2,395 | 2,457 | +78 | +3.3% | 103,000 |
2022/06/27 | 2,393 | 2,404 | 2,379 | 2,379 | -13 | -0.5% | 41,400 |
2022/06/24 | 2,375 | 2,395 | 2,362 | 2,392 | +30 | +1.3% | 55,900 |
2022/06/23 | 2,290 | 2,365 | 2,290 | 2,362 | +66 | +2.9% | 62,400 |
2022/06/22 | 2,279 | 2,306 | 2,269 | 2,296 | +46 | +2% | 63,900 |
2022/06/21 | 2,248 | 2,267 | 2,218 | 2,250 | +39 | +1.8% | 94,100 |
2022/06/20 | 2,238 | 2,253 | 2,200 | 2,211 | -27 | -1.2% | 69,100 |
2022/06/17 | 2,224 | 2,254 | 2,208 | 2,238 | -25 | -1.1% | 110,000 |
2022/06/16 | 2,250 | 2,275 | 2,250 | 2,263 | +23 | +1% | 71,800 |
551~
600
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム